drugset / Trial / NCT00005825

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00005825

Phase 2 Unknown Raghu Nandan, M.D., Inc
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Timeline

Start
1998-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified Intravenous
Subject Mitomycin C Other / unclassified Intravenous
Subject Tretinoin Small molecule Oral
Subject Vinorelbine Small molecule Intravenous

Indications